Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|June 26, 2001
Influence of cirrhosis on lamotrigine pharmacokineticsP Marcellin, F de Bony, C Garret, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?Th Delaunoit, M Ducreux, V Boige, et al.
Oncology|April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomasM P Ducreux, V Boige, S Leboulleux, et al.
ESMO Open|November 20, 2025
Precision medicine strategy in pancreatic ductal adenocarcinomaA Tarabay, L Swales, C Smolenschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patientsM Ducreux, E Mitry, M Ould-Kaci, et al.
International Journal of Pharmaceutics|August 15, 2017
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPECP Roy, C Canet-Jourdan, M Annereau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabD Malka, V Boige, N Jacques, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
Oncogene|November 3, 2009
Immunogenic death of colon cancer cells treated with oxaliplatinA Tesniere, F Schlemmer, V Boige, et al.
Pageof 8